Cargando…

Targeting BCR-ABL-Independent TKI Resistance in Chronic Myeloid Leukemia by mTOR and Autophagy Inhibition

BACKGROUND: Imatinib and second-generation tyrosine kinase inhibitors (TKIs) nilotinib and dasatinib have statistically significantly improved the life expectancy of chronic myeloid leukemia (CML) patients; however, resistance to TKIs remains a major clinical challenge. Although ponatinib, a third-g...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mitchell, Rebecca, Hopcroft, Lisa E M, Baquero, Pablo, Allan, Elaine K, Hewit, Kay, James, Daniel, Hamilton, Graham, Mukhopadhyay, Arunima, O’Prey, Jim, Hair, Alan, Melo, Junia V, Chan, Edmond, Ryan, Kevin M, Maguer-Satta, Véronique, Druker, Brian J, Clark, Richard E, Mitra, Subir, Herzyk, Pawel, Nicolini, Franck E, Salomoni, Paolo, Shanks, Emma, Calabretta, Bruno, Holyoake, Tessa L, Helgason, G Vignir
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2017
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5946859/ https://www.ncbi.nlm.nih.gov/pubmed/29165716 http://dx.doi.org/10.1093/jnci/djx236

Ejemplares similares

ATG7 regulates energy metabolism, differentiation and survival of Philadelphia-chromosome-positive cells
por: Karvela, Maria, et al.
Publicado: (2016)

Targeting mitochondrial oxidative phosphorylation eradicates therapy-resistant chronic myeloid leukemic stem cells
por: Kuntz, Elodie M., et al.
Publicado: (2017)

Signal Transducer and Activator of Transcription (STAT)5 Activation by BCR/ABL Is Dependent on Intact Src Homology (SH)3 and SH2 Domains of BCR/ABL and Is Required for Leukemogenesis
por: Nieborowska-Skorska, Malgorzata, et al.
Publicado: (1999)

The Antiproliferative Activity of Kinase Inhibitors in Chronic Myeloid Leukemia Cells Is Mediated by FOXO Transcription Factors
por: Pellicano, Francesca, et al.
Publicado: (2014)

T315I(+) tyrosine-kinase independent CML cells resistance
por: Nicolini, Franck Emmanuel, et al.
Publicado: (2017)

BCR-ABL tyrosine kinase inhibitor (TKI)-induced nephropathy: An under-recognized phenomenon
por: Stanchina, Michele, et al.
Publicado: (2020)

Expression of Constitutively Active Raf-1 in the Mitochondria Restores Antiapoptotic and Leukemogenic Potential of a Transformation-deficient BCR/ABL Mutant
por: Salomoni, Paolo, et al.
Publicado: (1998)

DRAM-3 modulates autophagy and promotes cell survival in the absence of glucose
por: Mrschtik, M, et al.
Publicado: (2015)

DRAM-3 modulates autophagy and promotes cell survival in the absence of glucose
por: Mrschtik, M, et al.
Publicado: (2017)

Impact of the Breakpoint Region on the Leukemogenic Potential and the TKI Responsiveness of Atypical BCR-ABL1 Transcripts
por: Massimino, Michele, et al.
Publicado: (2021)

Functional characterization of two rare BCR–FGFR1(+) leukemias
por: Barnes, Evan J., et al.
Publicado: (2020)

Validating a network hub in leukaemia stem cells
por: Hopcroft, Lisa E., et al.
Publicado: (2017)

Migrating to Long-Read Sequencing for Clinical Routine BCR-ABL1 TKI Resistance Mutation Screening
por: Schaal, Wesley, et al.
Publicado: (2022)

BH3 mimetics in combination with nilotinib or ponatinib represent a promising therapeutic strategy in blast phase chronic myeloid leukemia
por: Parry, Narissa, et al.
Publicado: (2022)

Susceptibility Of Ph-Positive All To Tki Therapy Associated With Bcr-Abl Rearrangement Patterns: A Retrospective Analysis
por: Jing, Yu, et al.
Publicado: (2014)

BCR‐ABL exon 7 deletion and novel point mutation in patient with chronic myelogenous leukemia and TKI resistance
por: Mikhailov, Ilya
Publicado: (2018)

Phosphorylation of Puma modulates its apoptotic function by regulating protein stability
por: Fricker, M, et al.
Publicado: (2010)

Expression of p89(c-Mybex9b), an alternatively spliced form of c-Myb, is required for proliferation and survival of p210BCR/ABL-expressing cells
por: Manzotti, G, et al.
Publicado: (2012)

BCR signaling contributes to autophagy regulation in chronic lymphocytic leukemia
por: Smith, Lindsay D., et al.
Publicado: (2019)

Navigating Challenges in Monitoring Chronic Myeloid Leukemia with Multiple BCR-ABL1 Transcripts
por: Smith, Brittany M., et al.
Publicado: (2021)

p73 engages A2B receptor signalling to prime cancer cells to chemotherapy-induced death
por: Long, J S, et al.
Publicado: (2015)

Targeting quiescent leukemic stem cells using second generation autophagy inhibitors
por: Baquero, Pablo, et al.
Publicado: (2018)

The Ins and Outs of Autophagy and Metabolism in Hematopoietic and Leukemic Stem Cells: Food for Thought
por: Ianniciello, Angela, et al.
Publicado: (2018)

Folate metabolism: a re-emerging therapeutic target in haematological cancers
por: Zarou, Martha M., et al.
Publicado: (2021)

Mitochondrial metabolism as a potential therapeutic target in myeloid leukaemia
por: de Beauchamp, Lucie, et al.
Publicado: (2021)

Androgens modulate autophagy and cell death via regulation of the endoplasmic reticulum chaperone glucose-regulated protein 78/BiP in prostate cancer cells
por: Bennett, H L, et al.
Publicado: (2010)

BCR-ABL1 kinase domain mutations may persist at very low levels for many years and lead to subsequent TKI resistance
por: Parker, W T, et al.
Publicado: (2013)

Unraveling Heterogeneity in the Aging Hematopoietic Stem Cell Compartment: An Insight From Single-cell Approaches
por: Yang, Fei, et al.
Publicado: (2023)

Metabolism in stem cell–driven leukemia: parallels between hematopoiesis and immunity
por: Rattigan, Kevin M., et al.
Publicado: (2023)

BMP2, a key to uncover luminal breast cancer origin linked to pollutant effects on epithelial stem cells niche
por: Chapellier, Marion, et al.
Publicado: (2015)

P685: LATE PHASE BCR-ABL DECLINE PREDICTS THE DURATION OF TKI (IMATINIB) FOR SUCCESSFUL TREATMENT FREE REMISSION IN CHRONIC MYELOID LEUKEMIA.
por: R, Chethan, et al.
Publicado: (2023)

MEK1/2 regulate normal BCR and ABL1 tumor-suppressor functions to dictate ATO response in TKI-resistant Ph+ leukemia
por: Mazzera, Laura, et al.
Publicado: (2023)

p53 directly regulates the glycosidase FUCA1 to promote chemotherapy-induced cell death
por: Baudot, Alice D., et al.
Publicado: (2016)

TKI safety
por: Hjorth-Hansen, Henrik
Publicado: (2019)

CDK4/CDK6 inhibition as a novel strategy to suppress the growth and survival of BCR-ABL1(T315I)+ clones in TKI-resistant CML
por: Schneeweiss-Gleixner, Mathias, et al.
Publicado: (2019)

FAM167A is a key molecule to induce BCR-ABL-independent TKI resistance in CML via noncanonical NF-κB signaling activation
por: Yang, Taewoo, et al.
Publicado: (2022)

Early Steps of Mammary Stem Cell Transformation by Exogenous Signals; Effects of Bisphenol Endocrine Disrupting Chemicals and Bone Morphogenetic Proteins
por: Jung, Nora, et al.
Publicado: (2019)

PTEN deficiency permits the formation of pancreatic cancer in the absence of autophagy
por: Rosenfeldt, Mathias T, et al.
Publicado: (2017)

Loss of autophagy affects melanoma development in a manner dependent on PTEN status
por: Rosenfeldt, Mathias T., et al.
Publicado: (2021)

mTORC1 Activation Requires DRAM-1 by Facilitating Lysosomal Amino Acid Efflux
por: Beaumatin, Florian, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_htjn6q4qa6suvsl7o9ui0lmrj8